Envoy Medical reports 12-month Acclaim cochlear implant trial data available

Envoy Medical posted 12-month data from the first 10 patients in its Acclaim fully implanted cochlear implant pivotal trial.

• Mean CNC word recognition rose to 53.2% from 15.2% pre-implant, extending the 6-month score of 39.2%.
• No serious adverse events were reported through 12 months in Stage 1.
• Stage 2 is fully enrolled; 12-month data collection is expected by early Q2 2027, with an FDA PMA filing planned months later.